![]() |
市场调查报告书
商品编码
1938331
行动式C臂市场 - 全球产业规模、份额、趋势、机会及预测(按类型、技术、应用、最终用户、地区和竞争格局划分),2021-2031年Mobile C-Arm Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technology, By Application, By End Users, By Region & Competition, 2021-2031F |
||||||
全球移动式 C 型臂市场预计将从 2025 年的 19.8 亿美元成长到 2031 年的 27.5 亿美元,复合年增长率为 5.63%。
这些多功能诊断影像设备在手术室中至关重要,可在心血管、整形外科和创伤手术中提供即时透视影像。其成长主要受以下因素驱动:全球慢性疾病负担日益加重,需要手术治疗;人口老化;以及微创手术(需要术中引导)的显着增加。英国国家医疗服务体系 (NHS) 2024 年的数据也印证了这项需求,数据显示,诊断影像检查的数量将达到 4,720 万例(比上一年增长 4.8%),其中透视手术量将增加 2.0%。这凸显了行动诊断影像设备对于提高手术精准度和改善病患预后的重要性。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 19.8亿美元 |
| 市场规模:2031年 | 27.5亿美元 |
| 复合年增长率:2026-2031年 | 5.63% |
| 成长最快的细分市场 | 平板 |
| 最大的市场 | 北美洲 |
然而,由于先进系统需要大量资本投资,而医疗机构预算紧张,市场成长面临许多障碍。高昂的实施和维护成本往往迫使小规模的医疗机构推迟设备升级,从而限制了最新技术的应用。此外,现有硬体的耐用性导致更换週期长,阻碍了市场快速渗透,儘管高端移动式C臂机具有明显的临床重要性,但製造商仍难以证明其投资回报率。
慢性病和整形外科疾病发生率的上升是全球移动式C臂市场的主要驱动力。随着人口老化,骨质疏鬆症和骨关节炎等与老龄化相关的疾病导致手术数量增加,尤其是骨折修復和关节重建。移动式C臂对于这些手术至关重要,因为它们可以提供高解析度的即时影像,从而实现精准的植入定位并降低再次手术率。美国关节重建註册中心于2025年10月发布的《2025年度报告》也印证了这一增长趋势,该报告指出,髋关节和膝关节关节重建手术的累积数量将超过440万例,比上一年增长8.8%。这表明,人们越来越依赖行动成像设备来应对肌肉骨骼疾病带来的负担。
同时,全球对微创手术 (MIS) 技术日益增长的需求正在改变市场动态。医疗服务提供者越来越注重能够减轻患者不适、缩短恢復时间的手术,并高度依赖移动式 C 型臂提供的先进透视引导技术,尤其是在脊柱和介入心臟病学等对精准度要求极高的手术中。西门子医疗于 2025 年 11 月发布的 2025 财年第四季度财务业绩反映了对介入设备的强劲需求,数据显示,该公司先进疗法部门的收入同比增长 3.8%。此外,通用电气医疗集团 2025 年 10 月的报告显示,由于诊断影像业务的强劲表现,其第三季总收入成长了 6%,这表明随着医疗机构不断提升诊断能力以适应复杂的工作流程,市场成长势头将持续强劲。
全球移动式C臂市场面临一个重大障碍:先进诊断影像设备的高昂购置成本,而医疗机构预算紧张加剧了这个问题。门诊中心和医院通常财务状况拮据,迫使管理者仔细评估每一笔资本支出。购置和维护设备的高成本阻碍了医疗机构更换老旧设备的意愿,导致老旧硬体长期使用。这种财务上的谨慎态度抑制了标准的更新换代週期,并成为市场成长的瓶颈,因为资金短缺延缓了采用新型、临床性能更优的移动式C臂系统进行复杂手术的进程。
近期产业统计也印证了这种投资延迟的趋势,这些数据凸显了财务压力的严峻性。根据美国医院协会 (AHA) 2025 年的数据,约 94% 的医疗机构管理者预计将推迟设备升级,以应对不断上涨的营运成本和关税相关成本。这种普遍推迟采购决策的做法直接限制了製造商将最尖端科技推向市场的能力。因此,儘管临床对术中影像的需求不断增长,但由于医疗机构面临如何证明新系统商业价值的财务挑战,市场扩张潜力仍然有限。
将人工智慧 (AI) 应用于即时影像优化和分析,以解决辐射安全和营运效率问题,正在从根本上改变市场格局。 AI 演算法被整合到移动式 C 型臂系统中,可自动定位患者并提高影像清晰度,从而降低累积辐射剂量并缩短手术时间。这种向智慧化生产力的转变,为专注于自动化工作流程技术以提高盈利的製造商带来了经济效益。根据 GE 医疗于 2024 年 10 月发布的“2024 财年第三季度财务业绩”,其影像事业部的息税前利润 (EBIT) 较上年同期增长了 18%。这项成功归功于透过先进的自动化功能来提高生产力的努力。
同时,移动影像技术与手术机器人导航系统的融合,正将C型臂的临床应用从基础诊断拓展至高阶术中导航。为了满足神经外科和脊椎外科手术所需的高精度要求,移动式C型臂的设计旨在与机器人平台无缝协作,从而建立一个用于植入放置和器械追踪的整合生态系统。近期财务表现也印证了市场对这类整合技术的需求。例如,史赛克公司于2024年10月发布的「2024年第三季财报电话会议记录」显示,其医疗外科和神经技术部门的外汇汇率收入增长了12.9%,这表明将可视化技术与手术导引相结合的系统正被迅速采用。
The Global Mobile C-Arm Market is projected to expand from USD 1.98 Billion in 2025 to USD 2.75 Billion by 2031, registering a CAGR of 5.63%. These versatile diagnostic imaging units are essential in operating rooms for providing real-time fluoroscopic visualization during cardiovascular, orthopedic, and trauma surgeries. Growth is primarily fuelled by the increasing global burden of chronic diseases and an aging population necessitating surgical care, alongside a significant transition toward minimally invasive procedures that require intraoperative guidance. This demand is illustrated by NHS England data from 2024, which showed diagnostic imaging activity hitting 47.2 million tests-a 4.8% annual rise-while fluoroscopy specifically increased by 2.0%, highlighting the critical need for mobile imaging to improve surgical accuracy and patient results.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.98 Billion |
| Market Size 2031 | USD 2.75 Billion |
| CAGR 2026-2031 | 5.63% |
| Fastest Growing Segment | Flat Panel |
| Largest Market | North America |
Conversely, market growth faces substantial hurdles due to the high capital investment needed for these sophisticated systems and the strict budget limitations within healthcare facilities. Elevated costs for acquisition and maintenance often force smaller institutions to postpone equipment updates, thereby limiting the uptake of modern technologies. Additionally, the durability of existing hardware results in a prolonged replacement cycle that hinders rapid market penetration, creating a challenge for manufacturers to prove the return on investment for high-end mobile C-arm models despite their obvious clinical importance.
Market Driver
The escalating incidence of chronic ailments and orthopedic disorders serves as a major driver for the Global Mobile C-Arm Market. With the geriatric demographic growing, age-associated conditions like osteoporosis and osteoarthritis are leading to a higher volume of surgical procedures, specifically fracture repairs and joint replacements. Mobile C-arms are essential for these operations, providing high-resolution, real-time imaging that facilitates precise implant positioning and lowers revision rates. This upward trend is evidenced by the American Joint Replacement Registry's '2025 Annual Report' from October 2025, which noted that cumulative hip and knee arthroplasty procedures exceeded 4.4 million, marking an 8.8% rise from the prior year and underscoring the increased reliance on mobile imaging to handle the musculoskeletal disease burden.
Simultaneously, the rising global preference for minimally invasive surgical (MIS) techniques is transforming market dynamics. Medical providers are increasingly favoring methods that reduce patient trauma and speed up recovery, which depend heavily on the advanced fluoroscopic guidance offered by mobile C-arms, especially in spinal and cardiovascular interventions where accuracy is critical. This strong demand for interventional tools is reflected in Siemens Healthineers' 'Q4 Fiscal Year 2025 Earnings Release' from November 2025, where the Advanced Therapies segment achieved a 3.8% year-over-year revenue growth. Furthermore, market momentum is supported by ongoing medical infrastructure investments, as seen in GE HealthCare's October 2025 report showing a 6% total revenue increase in the third quarter driven by imaging performance, suggesting a continued growth trend as facilities enhance their diagnostic capacities for complex workflows.
Market Challenge
The Global Mobile C-Arm Market faces a significant obstacle in the form of substantial capital requirements for advanced imaging units, exacerbated by tight budgetary limits within healthcare organizations. Outpatient centers and hospitals often function with slim financial margins, compelling administrators to carefully evaluate every capital expense. The high costs associated with acquiring and maintaining equipment discourage facilities from replacing older units, resulting in the extended use of legacy hardware. This financial prudence interrupts the standard replacement cycle and creates a bottleneck for market growth, as a lack of funding postpones the adoption of newer, clinically superior mobile C-arm systems needed for complex procedures.
This pattern of delayed investment is confirmed by recent industry statistics illustrating the gravity of financial strain. Data from the American Hospital Association in 2025 indicates that approximately 94% of healthcare administrators anticipated postponing equipment upgrades to cope with rising operational expenses and tariff-related costs. Such widespread deferral of purchasing decisions directly restricts manufacturers from introducing premium technologies to the market. Consequently, even with growing clinical demand for intraoperative imaging, the market's expansion potential remains limited by the economic challenges healthcare providers face in justifying the return on investment for new systems.
Market Trends
The incorporation of Artificial Intelligence for Real-Time Image Optimization and Analytics is fundamentally transforming the market by tackling issues of radiation safety and operational efficiency. AI algorithms are being embedded into mobile C-arm systems to automate patient positioning and improve image sharpness, which decreases both cumulative dose exposure and procedure duration. This evolution toward intelligent productivity offers financial benefits for manufacturers focusing on automated workflow technologies to boost profitability. As reported by GE HealthCare in their 'Third Quarter 2024 Financial Results' from October 2024, the Imaging segment achieved an 18% year-over-year rise in segment EBIT, a success credited to robust productivity efforts utilizing these advanced automated features.
At the same time, the merging of Mobile Imaging with Surgical Robotics and Navigation Systems is broadening the clinical application of C-arms from basic diagnostics to sophisticated intraoperative guidance. With neurosurgery and spinal procedures requiring elevated precision, mobile C-arms are being designed to communicate seamlessly with robotic platforms, forming a unified ecosystem for implant placement and instrument tracking. The demand for such integrated technologies is highlighted by recent financial results; for instance, Stryker's 'Q3 2024 Earnings Call Transcript' from October 2024 revealed that the MedSurg and Neurotechnology segment posted constant currency sales growth of 12.9%, demonstrating the fast-paced adoption of systems that combine visualization with surgical navigation.
Report Scope
In this report, the Global Mobile C-Arm Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Mobile C-Arm Market.
Global Mobile C-Arm Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: